Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1
Catalog Number:
SYB-CHB262
| Article Name: |
Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1 |
| Biozol Catalog Number: |
SYB-CHB262 |
| Supplier Catalog Number: |
CHB262 |
| Alternative Catalog Number: |
SYB-CHB262-100UG,SYB-CHB262-1MG |
| Manufacturer: |
Sanyou Bio |
| Category: |
Antikörper |
| Application: |
ELISA, FA, FACS, Kinetics |
| Species Reactivity: |
Human |
| Alternative Names: |
IMMU-130, hMN-14-SN38 |
| Labetuzumab govitecan is an ADC consisting of a CEACAM5-directed antibody and SN38 used for the study of various cancers including colorectal cancer. |
| Concentration: |
1mg/ml |
| Molecular Weight: |
157 kDa |
| Isotype: |
IgG1 |
| NCBI: |
06731 |
| UniProt: |
P06731 |
| Buffer: |
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2 |
| Purity: |
>90% |
| Form: |
Lyophilize |
| Target: |
CEACAM5 / CEA / CD66e |